Cancer and Diagnostics

Cancer Genomics & Metabolomics

Cancer genomics and metabolomics are two important fields of study that are helping researchers better understand the underlying biology of cancer and identify new targets for cancer treatments.

Cancer genomics involves the study of the genetic changes that occur in cancer cells. These changes can occur in various genes and pathways, leading to abnormal cell growth and division. By analyzing the genetic makeup of cancer cells, researchers can identify mutations and other changes that may be driving tumor growth, and develop new targeted therapies that specifically target these changes.

Metabolomics, on the other hand, focuses on the study of the metabolic changes that occur in cancer cells. Cancer cells have altered metabolic pathways that allow them to survive and grow under different conditions, including low oxygen levels and nutrient deprivation. By studying these metabolic pathways, researchers can identify new targets for cancer therapies, such as drugs that interfere with the cancer cell's ability to generate energy or metabolize nutrients.

Both cancer genomics and metabolomics are rapidly advancing fields that are helping to uncover new insights into the biology of cancer and identify new targets for cancer treatments. With ongoing research and advances in these fields, we may continue to see improvements in cancer treatment and outcomes for patients.